Medicines (Clinical Trials) Regulations 2016
Table of Contents
Enacting Formula
Part 1 GENERAL
1 Citation and commencement
2 Definitions
3 Scope of Regulations
Part 2 CLINICAL TRIALS OF MEDICINAL PRODUCTS
Division 1 — General
4 Sponsors
5 Principal investigator, etc.
6 Investigator’s brochure
Division 2 — Regulatory submissions for clinical trials of medicinal products
7 Requirement for clinical trial certificates
8 Application for clinical trial certificates
9 Conditions of clinical trial certificates
10 Amendments and substantial amendments to clinical trial, etc.
11 Notification of serious breaches and urgent safety measures
12 Notification of status of clinical trial
Division 3 — General duties
Subdivision 1 Good clinical practice and conduct of clinical trials
13 Conduct of clinical trials: good clinical practice
14 Conduct of clinical trials: in accordance with clinical trial certificates
15 Place of clinical trial
Subdivision 2 Duties relating to consents and provision of information
16 Consent of subjects, etc., in clinical trials
17 Consent of subjects, etc., in clinical trials in emergency situations
18 General requirements as to consent
19 Duty to give full explanation and information
20 Coercion
Subdivision 3 Duties relating to safety and interests of subjects
21 Urgent safety measures
22 Suspension or termination of clinical trial
Subdivision 4 Duties relating to information obtained and reports
23 Record of clinical trials
Division 4 — Vigilance
24 Notifications of serious adverse events
25 Notifications of unexpected serious adverse drug reactions
Division 5 — Labelling
26 Investigational medicinal product and auxiliary medicinal product labelling
Part 3 MISCELLANEOUS
27 Power to obtain information, etc.
28 Offences
Part 4 APPLICATION TO PENDING CLINICAL TRIALS
29 Revocation and pending clinical trials